Showing 4,841 - 4,860 results of 4,913 for search '"Hodgkin's lymphoma"', query time: 0.28s Refine Results
  1. 4841

    Gingival and alveolar ridge overgrowths: A histopathological evaluation from Saudi Arabia by Ibrahim Olajide Bello, Ahmed Qannam

    Published 2022-09-01
    “…The most common histologically diagnosed lesions were pyogenic granulomas (38%), fibromas (33%), peripheral ossifying fibromas (9%), squamous cell carcinomas (7%), peripheral giant cell granulomas (6%), neurofibromas (1%), and non-Hodgkin lymphomas (1%). Conclusion: Similar to what has been reported by most previous studies, reactive hyperplastic lesions were the most prevalent focal overgrowths found in the gingival and alveolar mucosae. …”
    Get full text
    Article
  2. 4842
  3. 4843

    Innovative Therapeutic Approaches in Primary Cutaneous B Cell Lymphoma by Claudia C. V. Lang, Claudia C. V. Lang, Egle Ramelyte, Egle Ramelyte, Reinhard Dummer, Reinhard Dummer

    Published 2020-08-01
    “…Background: Primary cutaneous B-cell lymphomas (pCBCL) include an infrequent group of non-Hodgkin lymphomas that are limited to skin sites at the time of diagnosis. …”
    Get full text
    Article
  4. 4844

    Impact of tuberculosis on HIV disease progression in persons with well-documented time of HIV seroconversion. by Del Amo, J, Pérez-Hoyos, S, Hernández Aguado, I, Díez, M, Castilla, J, Porter, K

    Published 2003
    “…Survival from HIV seroconversion shows that compared with AIDS-free subjects, the risk of death associated with TB as an initial ADC (hazard ratio [HR] = 23.23, 95% CI: 14.60-36.96) does not differ from that associated with Kaposi sarcoma (HR = 23.47, 95% CI: 16.66-33.05) or esophageal candidiasis (OC)/Pneumocystis carinii pneumonia (PCP) (HR = 30.97, 95% CI: 24.38-39.34) but is lower than that for opportunistic infections other than TB, OC/PCP (HR = 46.83, 95% CI: 37.86-47.94) and high-grade non-Hodgkin lymphomas/invasive cervical carcinoma (HR = 92.71, 95% CI: 60.83-141.3). …”
    Journal article
  5. 4845

    Expression of Apoptosis Related and Proliferative Proteins in Malignant Lympho-Proliferative Disorders by Zeeba Jairajpuri, Rekha Ghai, Sumita Saluja, Sujala Kapur, K.T Bhowmick

    Published 2017-07-01
    “…The expression of P53 and PCNA in 35 biopsies of Non Hodgkin Lymphomas (NHL) was found to increase from low to high grade tumors. …”
    Get full text
    Article
  6. 4846

    Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma by Wei Zhang, Li Yang, Yu’ Qi Guan, Ke’ Feng Shen, Mei’ Lan Zhang, Hao’ Dong Cai, Jia’ Chen Wang, Ying Wang, Liang Huang, Yang Cao, Na Wang, Xiao’ Hong Tan, Ken He Young, Min Xiao, Jian’ Feng Zhou

    Published 2020-07-01
    “…Abstract Background Diffuse large B-cell lymphoma (DLBCL) is a spectrum of disease comprising more than 30% of non-Hodgkin lymphomas. Although studies have identified several molecular subgroups, the heterogeneous genetic background of DLBCL remains ambiguous. …”
    Get full text
    Article
  7. 4847

    CAR T-Cells for CNS Lymphoma: Driving into New Terrain? by Philipp Karschnia, Jens Blobner, Nico Teske, Florian Schöberl, Esther Fitzinger, Martin Dreyling, Joerg-Christian Tonn, Niklas Thon, Marion Subklewe, Louisa von Baumgarten

    Published 2021-05-01
    “…Primary CNS lymphomas (PCNSL) represent a group of extranodal non-Hodgkin lymphomas and secondary CNS lymphomas refer to secondary involvement of the neuroaxis by systemic disease. …”
    Get full text
    Article
  8. 4848

    GM-CSF enhanced the effect of CHOP and R-CHOP on inhibiting diffuse large B-cell lymphoma progression via influencing the macrophage polarization by Yu Zhang, Jingjing Xiang, Xianfu Sheng, Ni Zhu, Shu Deng, Junfa Chen, Lihong Yu, Yan Zhou, Chenjun Lin, Jianping Shen

    Published 2021-03-01
    “…Abstract Background Diffuse large B-cell lymphoma (DLBCL) is a common type of the Non-Hodgkin lymphomas (NHLs) formed by the neoplastic transformation of mature B cells. …”
    Get full text
    Article
  9. 4849

    Hepatosplenic Gamma Delta T-Cell Lymphoma (HSGDTCL): Two Rare Case Reports from Western India by Irappa Madabhavi, Gaurang Modi, Harsha Panchal, Apurva Patel, Swaroop Revannasiddaiah, Asha Anand, Sonia Parikh, Kshitij Joshi, Malay Sarkar

    Published 2017-10-01
    “…Peripheral T cell lymphomas are a heterogeneous group of post-thymic, mature lymphoid malignancies, accounting for approximately 10-15% of all non-Hodgkin's lymphomas. Hepatosplenic T-cell lymphoma (HSGDTCL) is a rare entity, which is characterized by primary extra nodal disease with typical sinusoidal or sinusal infiltration of the liver and the spleen, respectively by expression of the T cell receptor   chain, and by a number of other frequent clinicopathologic features, including aggressive course of disease. …”
    Get full text
    Article
  10. 4850

    Risk of Cancer in Connective Tissue Diseases in Northeastern Italy over 15 Years by Elena Treppo, Federica Toffolutti, Valeria Manfrè, Martina Taborelli, Ginevra De Marchi, Salvatore De Vita, Diego Serraino, Luca Quartuccio

    Published 2022-07-01
    “…The most common cancers were breast (<i>n</i> = 34), lung (<i>n</i> = 24), colon–rectum–anus (<i>n</i> = 20), and non-Hodgkin lymphomas (NHL) (<i>n</i> = 20). Overall, no excess cancer risk was noted (SIR = 0.87), whereas the number of observed NHL cases was more than two-fold significantly higher than expected (SIR = 2.52). …”
    Get full text
    Article
  11. 4851

    Diffuse large B-cell lymphoma microenvironment displays a predominant macrophage infiltrate marked by a strong inflammatory signature by Leyre Serna, Peio Azcoaga, Manisha Brahmachary, Maria M. Caffarel, Maria M. Caffarel, Mounia S. Braza, Mounia S. Braza, Mounia S. Braza

    Published 2023-05-01
    “…Here, we exploited bioinformatic tools, TCGA data, and tumor tissue samples from patients with diffuse large B-cell lymphoma (DLBCL), one of the most frequent non-Hodgkin lymphomas of B-cell origin, to investigate the distribution of the different immune cell subpopulations in DLBCL samples in order to characterize the immune landscape of their microenvironment. …”
    Get full text
    Article
  12. 4852

    Modern approaches in the first line treatment of CD30-positive peripheral T-cell lymphomas by Irina V. Poddubnaya, Elena A. Bariakh, Sergei V. Voloshin, Liliia G. Gorenkova, Kamil D. Kaplanov, Alla M. Kovrigina, Nataliia B. Mikhailova, Tatiana I. Pospelova, Vadim V. Ptushkin, Gaiane S. Tumian, Natalia A. Falaleeva, Gulnara N. Khusainova

    Published 2021-05-01
    “…Peripheral T-cell lymphomas (PTCL) comprise a heterogeneous group of aggressive lymphoproliferative malignancies that account for approximately 10% of adult non-Hodgkins lymphomas. Despite the variety of PTCL subtypes, CHOP-like regimens are the standard first-line therapy in most cases. …”
    Get full text
    Article
  13. 4853

    An unusual presentation of gastric mucosa-associated lymphoid tissue (MALT)-type lymphoma by Bikram Shrestha, Bernard Kim, Alison Huffstetler

    Published 2016-09-01
    “…Mucosa-associated lymphoid tissue (MALT)-type lymphoma is a relatively rare disease; nevertheless, it is the third most common lymphoma type, accounting for 5–7% of all non-Hodgkin lymphomas. Case series and retrospective analysis published in the literature have suggested that extra gastrointestinal (GI) MALT-type lymphoma can occur simultaneously with MALT-type lymphoma involving the GI tract. …”
    Get full text
    Article
  14. 4854

    Clinicopathological profile of Waldenström's macroglobulinemia: Experience from a tertiary care center by Gautam Kumar Vasnik, S Venkatesan, Sanjeevan Sharma, Ajay Malik

    Published 2020-01-01
    “…It accounts for approx 2% of Non Hodgkin Lymphomas. The disease is slightly more common in elderly males, the median age at diagnosis being 63 years. …”
    Get full text
    Article
  15. 4855

    Patients with indolent lymphomas are at high risk of infections: experience from a German outpatient clinic by Christoph Lutz, Stefan Feiten, Geothy Chakupurakal, Jochen Heymanns, Jörg Thomalla, Christoph van Roye, Rudolf Weide

    Published 2023-01-01
    “…Abstract Background Patients with indolent B-cell non-Hodgkin lymphomas (B-NHLs) have an increased risk of infections which is caused by pathomechanisms of the diseases itself but also as a result of anti-tumor therapy. …”
    Get full text
    Article
  16. 4856

    RIPK1 is aberrantly expressed in multiple B-cell cancers and implicated in the underlying pathogenesis by Baoyu Wu, Jingyu Li, Han Wang, Jianguo Liu, Jiayong Li, Fang Sun, Dong chuan Feng

    Published 2023-07-01
    “…Abstract According to the latest epidemiology of the US, B-cell cancers account for > 3% of all new cancer cases and > 80% of non-Hodgkin lymphomas. However, the disease-modifying small molecular drug suitable for most B-cell cancers is still lacking. …”
    Get full text
    Article
  17. 4857
  18. 4858

    Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas by Fernando Gallardo, Ramon M. Pujol

    Published 2022-10-01
    “…Primary cutaneous lymphomas comprise a heterogeneous group of extranodal non-Hodgkin lymphomas (NHL) that arise from skin resident lymphoid cells and are manifested by specific lymphomatous cutaneous lesions with no evidence of extracutaneous disease at the time of diagnosis. …”
    Get full text
    Article
  19. 4859

    Diagnostic Capability of Next-Generation Sequencing Fusion Analysis in Identifying a Rare CASE of TRAF1-ALK-Associated Anaplastic Large Cell Lymphoma by Indu Agarwal, Linda Sabatini, Mir B. Alikhan

    Published 2020-05-01
    “…Background: Anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) is a rare T-cell neoplasm, accounting for approximately 3% of adult non-Hodgkin lymphomas. Although NPM1 is the most common fusion partner with ALK, many others have been described, necessitating break-apart FISH studies for confirmation of the diagnosis. …”
    Get full text
    Article
  20. 4860